Organon Canada launches Aybintio®, a biosimilar of the reference biologic Avastin®, providing a new option at a reduced cost for Canadians living with certain aggressive forms of cancer
KIRKLAND, QC , Nov. 7, 2022 /CNW/ - Organon (NYSE: OGN), a global women's health company, is announcing the launch and product availab...
